Vous avez cherché: 751,3 (Islandais - Anglais)

3
3.

3.
3rd

& 3
& 3

3 - >
3 - >

3 glös
3 bottles

3 mín.
3 min

3+1
chedule

3. ár (%)
year 3 (%)

3 flösku
3 bottles

3 klukkustunda.
3 hours.

+ 3 einingar
+3 units

3. stigs)
genotype 3 (n = 8)

millivefslungnasjúkdómuri (3%)
interstitial lung diseasei (3%)

(3. stigs)
c212 (phase 3)

p.g261fs*3
p.g261fs 3

tel: +31 (0)20 751 65 00
tel: +356 21 446205

Í klínískum iii. stigs rannsóknum sem tóku til 1680 sjúklinga (751 með spítalalungnabólgu og 929 með cssti), sem fengu 10 mg/kg af telavancíni á sólarhring, var greint frá aukaverkunum hjá 47,3% sjúklinga.
in phase 3 clinical trials involving 1680 patients (751 and 929, np and cssti, respectively) who received telavancin at a daily dose of 10 mg/kg, adverse reactions were reported in 47.3% of patients.